These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16160637)

  • 1. Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.
    Bennouna M; Greene VB; Defranoux L
    J Clin Psychopharmacol; 2005 Oct; 25(5):505-7. PubMed ID: 16160637
    [No Abstract]   [Full Text] [Related]  

  • 2. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Bogaisky M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109421
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
    Keefe RS; Sweeney JA; Gu H; Hamer RM; Perkins DO; McEvoy JP; Lieberman JA
    Am J Psychiatry; 2007 Jul; 164(7):1061-71. PubMed ID: 17606658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine improves cognition in schizophrenic patients stabilized on risperidone.
    Schubert MH; Young KA; Hicks PB
    Biol Psychiatry; 2006 Sep; 60(6):530-3. PubMed ID: 16806095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Freund-Levi Y; Jedenius E; Tysen-Bäckström AC; Lärksäter M; Wahlund LO; Eriksdotter M
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
    Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
    Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of galantamine added to clozapine on cognition of five patients with schizophrenia.
    Bora E; Veznedaroğlu B; Kayahan B
    Clin Neuropharmacol; 2005; 28(3):139-41. PubMed ID: 15965314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unsubstantiated conclusion.
    Reifler BV; Blazer D
    Am J Geriatr Psychiatry; 2015 Feb; 23(2):220. PubMed ID: 25575935
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Bogaiksy's letter to the editor.
    Freund-Levi Y; Jedenius E; Wahlund LO; Eriksdotter M; Tysen-Bäckström AC; Lärksäter M
    Am J Geriatr Psychiatry; 2014 Sep; 22(9):951. PubMed ID: 25109420
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of risperidone on cognition in patients with schizophrenia.
    Stip E; Lussier I
    Can J Psychiatry; 1996 Oct; 41(8 Suppl 2):S35-40. PubMed ID: 8899249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.
    Dyer MA; Freudenreich O; Culhane MA; Pachas GN; Deckersbach T; Murphy E; Goff DC; Evins AE
    Schizophr Res; 2008 Jul; 102(1-3):88-95. PubMed ID: 18325740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophrenia.
    Rosse RB; Deutsch SI
    Clin Neuropharmacol; 2002; 25(5):272-5. PubMed ID: 12410061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine for treatment-resistant schizophrenia.
    Allen TB; McEvoy JP
    Am J Psychiatry; 2002 Jul; 159(7):1244-5. PubMed ID: 12091212
    [No Abstract]   [Full Text] [Related]  

  • 16. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ; Rabinowitz J
    Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement?
    Norén U; Björner A; Sonesson O; Eriksson L
    Schizophr Res; 2006 Jul; 85(1-3):302-4. PubMed ID: 16675200
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study.
    Procyshyn RM; Barr AM; Flynn S; Schenk C; Ganesan S; Honer WG
    Schizophr Res; 2010 Nov; 123(2-3):273-5. PubMed ID: 20688481
    [No Abstract]   [Full Text] [Related]  

  • 19. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
    Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
    J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All antipsychotics are equal, but some are more equal than others.
    Volavka J; Citrome L
    J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.